Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFollicular lymphoma was added to the conditions section and the Genetic and Rare Diseases Information Center resources reference was included.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a new UI revision label 'Revision: v3.4.2' replacing the previous 'Revision: v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedMinor site version update from v3.4.0 to v3.4.1 with no visible changes to the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedA new metadata revision tag 'Revision: v3.3.4' was added and the previous tag 'Revision: v3.3.3' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.